SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-09-004032
Filing Date
2009-05-15
Accepted
2009-05-15 13:43:09
Documents
6
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 ALSERES PHARMACEUTICALS, INC. FORM 10-Q b75213ape10vq.htm 10-Q 259837
2 EX-10.6 SECURITIES PURCHASE AGREEMENT ROBERT L. GIPSON b75213apexv10w6.htm EX-10.6 70339
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b75213apexv31w1.htm EX-31.1 8316
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b75213apexv31w2.htm EX-31.2 8158
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO b75213apexv32w1.htm EX-32.1 3284
6 EX-32.2 SECTION 906 CERTIFICATION OF CFO b75213apexv32w2.htm EX-32.2 3605
  Complete submission text file 0000950135-09-004032.txt   355250
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-06533 | Film No.: 09831282
SIC: 2834 Pharmaceutical Preparations